Studies have shown high grade EC has a high percentage of HER-2/neu overexpression (17%) and gene amplification (21%).15 This is consistent with the results of this study in which there were 12 high grade carcinomas out of which 4(33.3%) cases over expressed HER-2/neu by immunohistochemistry. This evidence concerns the gene ERBB2 and carcinoma.